Saiprasad Gowrikumar

2PUBLICATIONS
6CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Sep 28, 2021
A Claudin-Based Molecular Signature Identifies High-Risk, Chemoresistant Colorectal Cancer Patients.

Saiprasad Gowrikumar, Mark Primeaux, Kristina Pravoverov

|May 05, 2021
PIK3C3 Inhibition Promotes Sensitivity to Colon Cancer Therapy by Inhibiting Cancer Stem Cells.

Balawant Kumar, Rizwan Ahmad, Swagat Sharma

Pageof 1